Duncker Streett & Co. Inc. Makes New Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Duncker Streett & Co. Inc. purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent disclosure with the SEC. The fund purchased 2,765 shares of the medical equipment provider's stock, valued at approximately $1,369,000.

Several other hedge funds and other institutional investors have also modified their holdings of ISRG. Brighton Jones LLC raised its stake in shares of Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after purchasing an additional 731 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $6,509,000. Bank Pictet & Cie Europe AG boosted its stake in Intuitive Surgical by 0.5% in the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after buying an additional 883 shares in the last quarter. Fisher Funds Management LTD bought a new stake in Intuitive Surgical in the fourth quarter valued at $86,676,000. Finally, Wealthspire Advisors LLC raised its stake in Intuitive Surgical by 28.6% during the fourth quarter. Wealthspire Advisors LLC now owns 1,645 shares of the medical equipment provider's stock worth $859,000 after acquiring an additional 366 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Erste Group Bank raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Thursday, June 5th. Royal Bank Of Canada reduced their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Robert W. Baird dropped their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Barclays cut their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research report on Thursday, April 24th. Finally, BTIG Research set a $560.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $588.95.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now directly owns 6,371 shares in the company, valued at approximately $3,312,920. This trade represents a 27.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president now owns 907 shares of the company's stock, valued at $510,740.77. This trade represents a 19.23% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,998 shares of company stock valued at $2,611,577. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded up $7.99 during mid-day trading on Tuesday, hitting $523.08. The company had a trading volume of 1,593,560 shares, compared to its average volume of 1,675,751. The firm has a market cap of $187.48 billion, a P/E ratio of 76.70, a P/E/G ratio of 5.46 and a beta of 1.67. The business's fifty day moving average is $529.22 and its two-hundred day moving average is $536.97. Intuitive Surgical, Inc. has a fifty-two week low of $413.82 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 EPS. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.